OR WAIT null SECS
June 10, 2025
In the third part of her Pharma Commerce video interview, Maggie McCullough, PolicyMap’s CEO, comments on how mobile and digital solutions can be deployed effectively to close the gap in areas identified as pharmacy deserts.
June 09, 2025
In an effort to greater prepare HCPs and to avoid potential shortages, the company targets Q3 as the shipment date.
In order to succeed in today’s outcomes-driven healthcare landscape, pharmaceutical companies must move from traditional sales models to strategic, measurable partnerships with integrated delivery networks (IDNs).
June 06, 2025
A cross-sectional study explores how full-benefit dual-eligible beneficiaries differ across MA plans with differing levels of Medicaid coordination and integration.
June 03, 2025
Direct-to-consumer and direct-to-patient models are major contributors.
May 28, 2025
The rebrand creates a platform that is expected enhance the way life sciences companies bring their therapies to market.
May 23, 2025
Bruce Leuchter, CEO, Neurvati, discusses the indispensable role of patient advocates—particularly in rare and serious disease drug development—in shaping trial design, site selection, and regulatory strategy.
May 21, 2025
The telehealth site will welcome its own small-dose, compounded version of semaglutide, which mimics the function of a GLP-1.
May 20, 2025
An NEJM study explores how this loss—following Medicaid disenrollment—affects beneficiaries.
May 15, 2025
A qualitative study aimed to strengthen systematic repurposing efforts within rare disease nonprofit organizations, while also providing a framework for data-driven drug repurposing.